BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 12034052)

  • 1. Thyroid disease and lipids.
    Duntas LH
    Thyroid; 2002 Apr; 12(4):287-93. PubMed ID: 12034052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
    Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
    Tan KC; Shiu SW; Kung AW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2921-4. PubMed ID: 9709970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.
    Sigal GA; Tavoni TM; Silva BMO; Kalil Filho R; Brandão LG; Maranhão RC
    Thyroid; 2019 Jan; 29(1):53-58. PubMed ID: 30412041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thyroid disorders on lipid levels and metabolism.
    Duntas LH; Brenta G
    Med Clin North Am; 2012 Mar; 96(2):269-81. PubMed ID: 22443975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment.
    Brenta G; Berg G; Arias P; Zago V; Schnitman M; Muzzio ML; Sinay I; Schreier L
    Thyroid; 2007 May; 17(5):453-60. PubMed ID: 17542675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid diseases, dyslipidemia and cardiovascular risk].
    Jiskra J; Límanová Z; Antosová M
    Vnitr Lek; 2007 Apr; 53(4):382-5. PubMed ID: 17578170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
    Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
    Heimberg M; Olubadewo JO; Wilcox HG
    Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism.
    Asami T; Ciomartan T; Uchiyama M
    Pediatr Int; 1999 Jun; 41(3):266-9. PubMed ID: 10365575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
    Luboshitzky R; Aviv A; Herer P; Lavie L
    Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.
    Müller MJ; Seitz HJ
    Klin Wochenschr; 1984 Jan; 62(2):49-55. PubMed ID: 6708390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
    Sucić M; Bozikov V; Mesić R; Sokolić L
    Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis.
    Kotwal A; Cortes T; Genere N; Hamidi O; Jasim S; Newman CB; Prokop LJ; Murad MH; Alahdab F
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32954428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid hormones and the metabolism of lipoproteins].
    Berthezene F; Perrot L; De Parscau L; Valentin C; Richard L
    Ann Endocrinol (Paris); 1983; 44(1):73-6. PubMed ID: 6347029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.
    Pazos F; Alvarez JJ; Rubiés-Prat J; Varela C; Lasunción MA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):562-6. PubMed ID: 7852521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.
    Ikewaki K; Nishiwaki M; Sakamoto T; Ishikawa T; Fairwell T; Zech LA; Nagano M; Nakamura H; Brewer HB; Rader DJ
    J Clin Invest; 1995 Sep; 96(3):1573-81. PubMed ID: 7657828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.